LUND, Sweden I June 12, 2019 I BioInvent International AB (BINV) today announces the publication of the first data from two parallel Phase l/lla clinical trials of its lead product candidate BI-1206 as single agent and/or in combination with rituximab, currently being...
The Australasian Leukaemia and Lymphoma Group (ALLG) are pleased to announce the launch of the APML5 interim clinical trial results at the 24th Congress of the European Hematology Association (EHA) in Amsterdam in June 2019. The interim results show promise for an...
Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate Based on DSMB clearance, two lead dosage levels have been selected for ongoing Phase 2 clinical development Saint-Herblain (France), June 12, 2019 – Valneva SE (“Valneva” or...
Software is playing a growing role in clinical trials, and over the years it’s been introduced as a tool to help enroll patients, collect data, and analyze results. But one aspect of clinical trial record-keeping has been stubbornly stuck on paper—the reporting of...
Phase 1 study will evaluate the safety and tolerability of TERN-101, an FXR agonist in development for the treatment of NASH FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)– Terns Pharmaceuticals, Inc. today announced the initiation of a Phase 1...
Clinical trials are crucial for new product and device development and are required by the Food and Drug Administration (FDA) before approvals can be granted for their use in the general population. Overall success is dependent on sponsors to supply clinically valid...
Email
Text